Skip to main content

Table 1 Patient characteristics

From: In vivo generated autologous plasmin assisted vitrectomy in young patients

Age Gender/eye Diagnosis Inj-Op ınterval (day) Treatment No of attempts for PVD Preop VA LogMAR Postop VA LogMAR Final status Follow-up time (month) Complication
39 M/L Chronic RD 3 PPV, LE 3 2.00 0.70 Attached 23 None
12 F/L Chronic RD 3 PPV 2 2.40 0.70 Attached 18 Re-RD
31 F/R Chronic RD 3 PPV 3 2.40 1.00 Attached 14 ERM
17 M/R Traumatic RD 3 PPV, LE 1 1.00 0.70 Attached 14 None
13 M/L Traumatic RD 3 PPV, LE 3 0.70 0.20 Attached 26 None
12 F/L OPM 3 PPV 4 1.30 0.30 Attached 14 None
39 M/R Traumatic RD 3 PPV 1 1.80 0.70 Attached 15 None
39 F/L VPT 3 PPV 2 1.30 0.10 Attached 26 None
10 M/R MH 3 PPV 2 1.00 0.70 Attached 25 None
19 M/R VPT 3 PPV, LE 2 2.00 0.40 Attached 23 None
29 F/L Chronic RD 3 PPV 1 1.30 0.10 Attached 12 None
23 F/R Chronic RD 3 PPV, LE 2 1.80 0.50 Attached 18 None
21 M/L VPT 3 PPV, LE 2 1.00 1.00 Attached 25 Re-RD
21 F/L OPM 3 PPV 2 1.30 0.70 Attached 14 None
19 M/L VPT 3 PPV, LE 2 0.50 0.50 Attached 23 ERM, Re-RD
24 F/L Chronic RD 3 PPV, LE 1 1.30 0.40 Attached 23 None
33 M/R Chronic RD 3 PPV, LE 1 0.50 0.10 Attached 16 None
  1. PPV, pars plana vitrectomy; Inj-Op, ınjection-operation; PVD, Posterior vitreous detachment; VA, visual acuity; RD, retinal detachment; SiO, silicone oil; LE, lens extraction; MH, macular hole; OPM, optic pit maculopathy; VPT, vasoproliferative tumor